RARE DISEASERESEARCH ATLAS

ORPHA:91413

Congenital Horner syndrome

high confidenceDisorder

Also known as: Congenital Claude-Bernard-Horner syndrome

Query health: suspect — Only one of 2 strategies returned hits (phrase).

Publications

146

55.8th percentile

Trials

0

Interventional, condition-specific

Researchers

1,187

Distinct authors in sample

Gene link

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

Horner syndrome is a rare neurological disorder characterized by relative pupillary miosis and blepharoptosis, evident at birth, caused by interruption of the oculosympathetic innervation at any point along the neural pathway from the hypothalamus to the orbit. Often additional symptoms, such as enophthalmos, facial anhidrosis, iris heterochromia, conjunctival congestion, transient and/or pupillary dilation lag, may be present. Association with birth trauma, neoplasms or vascular malformations has been reported.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (3)

congenital Claude-Bernard-Horner syndrome · congenital Horner syndrome · congenital Horner syndrome (disease)

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    146 matched papers (57 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 1 for broader category Horner syndrome

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

146

146 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

146 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

57 in the last 10 years · high confidence · 55.8th percentile (publications denominator)

Phrase hits: 146 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,187

Distinct author names in 146 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Zhang Y10 papers · 2016

    Duke University, Durham, NC USA

    Papers in Europe PMC
  2. 02
    Konofagou E9 papers · 2016

    Columbia University, New York, NY USA

    Papers in Europe PMC
  3. 03
    McDannold N9 papers · 2016

    Brigham and Women’s Hospital, Harvard Medical School, Boston, MA USA

    Papers in Europe PMC
  4. 04
    Pauly K9 papers · 2016

    Stanford University, Stanford, CA USA

    Papers in Europe PMC
  5. 05
    Preusser T9 papers · 2016

    Philips Research, Eindhoven, Netherlands

    Papers in Europe PMC
  6. 06
    Partanen A8 papers · 2016

    Philips, Bethesda, MD USA

    Papers in Europe PMC
  7. 07
    Payne A8 papers · 2016

    University of Utah, Salt Lake City, UT USA

    Papers in Europe PMC
  8. 08
    Xu Z8 papers · 2016

    University of Michigan, Ann Arbor, MI USA

    Papers in Europe PMC
  9. 09
    Frank J7 papers · 2016

    National Institutes of Health Clinical Center, Bethesda, MD USA

    Papers in Europe PMC
  10. 10
    Parker D7 papers · 2016

    University of Utah, Salt Lake City, UT USA

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1 trial are registered for Horner syndrome, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

1 interventional trial matched Horner syndrome, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: Horner syndrome

1

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Congenital Horner syndrome" OR "Congenital Claude-Bernard-Horner syndrome" OR "congenital Horner syndrome (disease)"

Run this search on Europe PMC

MeSH descriptor terms unioned into the query: Horner Syndrome, Congenital

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Congenital Horner syndrome" OR "Congenital Claude-Bernard-Horner syndrome" OR "congenital Horner syndrome (disease)" OR "Horner Syndrome, Congenital"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"Horner syndrome"

Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T04:02:15.400Z